Browse our 650+ Publications​

Latest Publications

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

Huang et al.
Nature
Papers
April 2017
Authors and Affiliates
Alexander C. Huang1,2,3,4, Michael A. Postow5,6, Robert J. Orlowski1,2,3,4, Rosemarie Mick3,4,7, Bertram Bengsch2,4,8, Sasikanth Manne2,8, Wei Xu1,3, Shannon Harmon1,3, Josephine R. Giles2,4,8, Brandon Wenz1,3, Matthew Adamow9, Deborah Kuk10, Katherine S. Panageas10, Cristina Carrera5,11, Phillip Wong9,12, Felix Quagliarello2,8, Bradley Wubbenhorst1,3, Kurt D’Andrea1,3, Kristen E. Pauken2,8, Ramin S. Herati1,2,3, Ryan P. Staupe2,8, Jason M. Schenkel13, Suzanne McGettigan1,3, Shawn Kothari1, Sangeeth M. George2,4,8, Robert H. Vonderheide1,2,3,4, Ravi K. Amaravadi1,3, Giorgos C. Karakousis3,14, Lynn M. Schuchter1,3, Xiaowei Xu3,15, Katherine L. Nathanson1,3,4, Jedd D. Wolchok5,12, Tara C. Gangadhar1,3, and E. John Wherry2,3,4,8 1Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 4Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, Pennsylvania, USA. 5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 6Weill Cornell Medical College, New York, New York, USA. 7Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 8Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 9Immune Monitoring Facility, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 10Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 11Department of Dermatology, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain. 12Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, New York, USA. 13Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, USA. 14Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 15Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

Stevanović et al.
Papers
Science
April 2017
Authors and Affiliates
Sanja Stevanović,1 Anna Pasetto,2 Sarah R. Helman,1 Jared J. Gartner,2 Todd D. Prickett,2 Bryan Howie,3 Harlan S. Robins,3,4 Paul F. Robbins,2 Christopher A. Klebanoff,5,6 Steven A. Rosenberg,2 Christian S. Hinrichs1 1Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD 20892, USA. 2Surgery Branch, National Cancer Institute, Bethesda, MD 20892, USA. 3Adaptive Biotechnologies, Seattle, WA 98102, USA. 4Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. 5Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 6Parker Institute for for Cancer Immunotherapy, New York, NY 10065, US

Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox

Ogunjimi et al.
Papers
Scientific Reports
April 2017
Authors and Affiliates
B. Ogunjimi 1,2,3,4,5,6, J. Van den Bergh4, P. Meysman6,7,8, S. Heynderickx4,9, K. Bergs10, H. Jansen10, E. Leuridan11, A. Vorsters11, H. Goossens10,12, K. Laukens6,7,8, N. Cools4, Viggo Van Tendeloo4,6,9, N. Hens1,2,6, P. Van Damme6,11, Evelien Smits4,6,9,13 & Ph. Beutels1,6,14 1Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium. 2Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Hasselt, Belgium. 3Department of Pediatrics, Antwerp University Hospital, Edegem, Belgium. 4Laboratory of Experimental Hematology (LEH), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium. 5Department of Pediatrics, Ghent University Hospital, Ghent, Belgium. 6Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), Antwerp, Belgium. 7Advanced Database Research and Modelling (ADReM), Department of Mathematics and Computer Science, University of Antwerp, Antwerp, Belgium. 8Biomedical Informatics Research Network Antwerp (BIOMINA), University of Antwerp/Antwerp University Hospital, Edegem, Belgium. 9Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium. 10Department of Laboratory Medicine, Antwerp University Hospital, Edegem, Belgium. 11Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium. 12Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium. 13Center for Oncological Research Antwerp, University of Antwerp, Antwerp, Belgium. 14School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia.

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

Roh et al.
Papers
Science Translational Medicine
March 2017
Authors and Affiliates
Whijae Roh,1,2 Pei-Ling Chen,1,3 Alexandre Reuben,4 Christine N. Spencer,1 Peter A. Prieto,4 John P. Miller,5 Vancheswaran Gopalakrishnan,4 Feng Wang,1 Zachary A. Cooper,1,4 Sangeetha M. Reddy,6 Curtis Gumbs,1 Latasha Little,1 Qing Chang,1 Wei-Shen Chen,1,3 Khalida Wani,7 Mariana Petaccia De Macedo,7,8 Eveline Chen,7 Jacob L. Austin-Breneman,4 Hong Jiang,4 Jason Roszik,1,9 Michael T. Tetzlaff,3 Michael A. Davies,9 Jeffrey E. Gershenwald,4 Hussein Tawbi,9 Alexander J. Lazar,4,7 Patrick Hwu,9 Wen-Jen Hwu,9 Adi Diab,9 Isabella C. Glitza,9 Sapna P. Patel,9 Scott E. Woodman,9 Rodabe N. Amaria,9 Victor G. Prieto,3 Jianhua Hu,10 Padmanee Sharma,11,12 James P. Allison,11 Lynda Chin,13 Jianhua Zhang,14 Jennifer A. Wargo,1,4 P. Andrew Futreal1 1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 2Cancer Biology Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA. 3Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 4Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 5Oncology Research for Biologics and Immunotherapy Translation, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 6Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 7Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 8Pathology Department, A.C. Camargo Cancer Center, São Paulo, SP-01509-010, Brazil. 9Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 10Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 11Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 12Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 13University of Texas System, Austin, TX 78701, USA. 14Applied Cancer Science Institute, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

The Lower Limit of Regulatory CD4+ Foxp3+ TCRb Repertoire Diversity Required To Control Autoimmunity

Yu et al.
Journal of Immunology
Papers
March 2017
Authors and Affiliates
Aixin Yu,* Michael J. Dee,* Dennis Adeegbe,*, Connor J. Dwyer,* Norman H. Altman,† and Thomas R. Malek*,‡ *Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136; †Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136; and ‡Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136

High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis

Lombardo et al.
Blood
Papers
March 2017
Authors and Affiliates
Katharine A. Lombardo,1,2 David G. Coffey,1,3 Alicia J. Morales,1 Christopher S. Carlson,4 Andrea M. H. Towlerton,1 Sarah E. Gerdts,5 Francis K. Nkrumah,6 Janet Neequaye,7 Robert J. Biggar,8 Jackson Orem,9 Corey Casper,1,3-5,10,11 Sam M. Mbulaiteye,12 Kishor G. Bhatia,12 and Edus H. Warren1,3 1Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; 2Molecular and Cellular Biology Program and 3Department of Medicine, School of Medicine, University of Washington, Seattle, WA; 4Division of Public Health Sciences and 5Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA; 6Noguchi Institute for Medical Research and 7Department of Child Health, Medical School, University of Ghana, Accra, Ghana; 8Institute of Health and Biotechnical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; 9Uganda Cancer Institute, Kampala, Uganda; 10Department of Global Health, School of Medicine, and 11Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA; and 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD

Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens

Khodadoust et al.
Nature
Papers
March 2017
Authors and Affiliates
Michael S. Khodadoust1, Niclas Olsson2, Lisa E. Wagar3, Ole A. W. Haabeth1, Binbin Chen1,4, Kavya Swaminathan2, Keith Rawson2, Chih Long Liu1, David Steiner5, Peder Lund3, Samhita Rao2, Lichao Zhang2, Caleb Marceau3, Henning Stehr1, Aaron M. Newman1,6, Debra K. Czerwinski1, Victoria E. H. Carlton7, Martin Moorhead7, Malek Faham7, Holbrook E. Kohrt1, Jan Carette3, Michael R. Green1, Mark M. Davis3,8, Ronald Levy1, Joshua E. Elias2 & Ash A. Alizadeh1,6,9 1Department of Medicine, Division of Oncology, Stanford University, Stanford, California 94305, USA. 2Department of Chemical & Systems Biology, Stanford University, Stanford, California 94305, USA. 3Department of Microbiology & Immunology, Stanford University, Stanford, California 94305, USA. 4Department of Genetics, Stanford University, Stanford, California 94305, USA. 5Department of Pathology, Stanford University, Stanford, California 94305, USA. 6Center for Cancer Systems Biology, Stanford University, Stanford, California 94305, USA. 7Adaptive Biotechnologies, South San Francisco, California 94080, USA. 8Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA. 9Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, California 94305, USA.

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity

Juneja et al.
Journal of Experimental Medicine
Papers
March 2017
Authors and Affiliates
Vikram R. Juneja,1,2,5 Kathleen A. McGuire,2,5 Robert T. Manguso,3,6 Martin W. LaFleur,2,5,6 Natalie Collins,4,6,8 W. Nicholas Haining,4,6,8 Gordon J. Freeman,7 and Arlene H. Sharpe2,5 1Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, 2Department of Microbiology and Immunobiology, 3Division of Medical Sciences, and 4Division of Hematology/Oncology, Children's Hospital, Harvard Medical School, Boston, MA 02115, 5Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA 02115, 6Department of Pediatric Oncology and 7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, 8Broad Institute of MIT and Harvard, Cambridge, MA 02142

T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas

Pollack et al.
Cancer
Papers
March 2017
Authors and Affiliates
Seth M. Pollack, MD1,2; Qianchuan He, PhD1,3; Jennifer H. Yearley, PhD4; Ryan Emerson, PhD5; Marissa Vignali, PhD5; Yuzheng Zhang, MA1,3; Mary W. Redman, PhD1; Kelsey K. Baker, MA1; Sara Cooper, MS1; Bailey Donahue, BS1; Elizabeth T. Loggers, MD, PhD1,2; Lee D. Cranmer, MD, PhD1,2; Matthew B. Spraker, MD, PhD6; Y. David Seo, MD7; Venu G. Pillarisetty, MD7; Robert W. Ricciotti, MD8; Benjamin L. Hoch, MD8; Terrill K. McClanahan, PhD4; Erin Murphy, BS4; Wendy M. Blumenschein, BA4; Steven M. Townson, PhD4; Sharon Benzeno, PhD5; Stanley R. Riddell, MD, PhD1,2,9; and Robin L. Jones, MD1,2,10 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 2Department of Medicine, University of Washington, Seattle, Washington; 3Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 4Merck & Co., Inc. Kenilworth New Jersey; 5Adaptive Biotechnologies Corporation, Seattle, Washington; 6Department of Radiation Oncology, University of Washington, Seattle, Washington; 7Department of Surgery, University of Washington, Seattle, Washington; 8Department of Pathology, University of Washington, Seattle, Washington; 9Institute for Advanced Study, Technical University of Munich, Munich, Germany; 10Royal Marsden Hospital and Institute of Cancer Research, London.

Neutrophils dominate the immune cell composition in non-small cell lung cancer

Kargl et al.
Nature Communications
Papers
February 2017
Authors and Affiliates
Julia Kargl1,2, Stephanie E. Busch1, Grace H.Y. Yang1, Kyoung-Hee Kim1, Mark L. Hanke1, Heather E. Metz1, Jesse J. Hubbard1, Sylvia M. Lee1, David K. Madtes1,3, Martin W. McIntosh4 & A. McGarry Houghton1,3,5 1Clinical Research Division, Seattle, Washington 98109, USA. 2Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Universitaetsplatz 4, Graz 8010, Austria. 3Division of Pulmonary and Critical Care Medicine, University of Washington, Campus Box 356522, Seattle, Washington 98195-6522, USA. 4Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, Washington 98109, USA. 5Human Biology Division, Seattle, Washington 98109, USA
Previous Next